CSD500 Progress

RNS Number : 4876Y
Futura Medical PLC
23 December 2010
 



 

For immediate release

23 December 2010

 

 

 

Futura Medical plc

("Futura" or "the Company")

 

CSD500 Progress

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces a year-end progress update on CSD500, the innovative condom designed to help healthy men maintain a firmer erection.

The Board considers that all outstanding points raised by the Notified Body for CSD500's CE mark have been addressed by Reckitt Benckiser and, based on recent discussions; we believe a decision is imminent. The upcoming Christmas holiday period means that the timing of the decision may be early in 2011. 

 

For any further information please contact:

 

Futura Medical plc

 

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

 

 

mail to: james.barder@futuramedical.com

www.futuramedical.com

 

 

Nomura Code Securities Limited

 

Phil Walker / Giles Balleny

Tel:+44 (0)20 7776 1200

 

 

For media enquiries please contact:

 

 

 

Buchanan Communications

 

Mark Court / Jessica Fontaine

Tel: +44 (0) 20 7466 5000

 

 

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

 

www.futuramedical.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFEDESEFSSESE
UK 100

Latest directors dealings